The Parkinson's Disease Protein LRRK2 Interacts with the GARP Complex to Promote Retrograde Transport to the trans-Golgi Network

被引:44
|
作者
Beilina, Alexandra [1 ]
Bonet-Ponce, Luis [1 ]
Kumaran, Ravindran [1 ]
Kordich, Jennifer J. [2 ]
Ishida, Morie [3 ]
Mamais, Adamantios [1 ]
Kaganovich, Alice [1 ]
Saez-Atienzar, Sara [1 ]
Gershlick, David C. [3 ]
Roosen, Dorien A. [1 ,4 ]
Pellegrini, Laura [1 ,5 ]
Malkov, Vlad [6 ]
Fell, Matthew J. [6 ]
Harvey, Kirsten [5 ]
Bonifacino, Juan S. [3 ]
Moore, Darren J. [2 ]
Cookson, Mark R. [1 ]
机构
[1] NIA, Lab Neurogenet, NIH, Bethesda, MD 20814 USA
[2] Van Andel Res Inst, Ctr Neurodegenerat Sci, Grand Rapids, MI 49503 USA
[3] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Cell Biol & Neurobiol Branch, NIH, Bethesda, MD 20814 USA
[4] Univ Reading, Sch Pharm, Reading RG6 6AP, Berks, England
[5] UCL, UCL Sch Pharm, Dept Pharmacol, 29-39 Brunswick Sq, London WC1N 1AX, England
[6] Merck & Co Inc, 33 Ave Louis Pasteur, Boston, MA 02115 USA
来源
CELL REPORTS | 2020年 / 31卷 / 05期
关键词
KINASE; 2; LRRK2; ALPHA-SYNUCLEIN; R1441C MUTATION; CATHEPSIN-D; ENDOSOME; DEGRADATION; NEURODEGENERATION; DYSFUNCTION; ASSOCIATION; INHIBITORS;
D O I
10.1016/j.celrep.2020.107614
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Mutations in Leucine-rich repeat kinase 2 (LRRK2) cause Parkinson's disease (PD). However, the precise function of LRRK2 remains unclear. We report an interaction between LRRK2 and VPS52, a subunit of the Golgi-associated retrograde protein (GARP) complex that identifies a function of LRRK2 in regulating membrane fusion at the trans-Golgi network (TGN). At the TGN, LRRK2 further interacts with the Golgi SNAREs VAMP4 and Syntaxin-6 and acts as a scaffolding platform that stabilizes the GARP-SNAREs complex formation. Therefore, LRRK2 influences both retrograde and post-Golgi trafficking pathways in a manner dependent on its GTP binding and kinase activity. This action is exaggerated by mutations associated with Parkinson's disease and can be blocked by kinase inhibitors. Disruption of GARP sensitizes dopamine neurons to mutant LRRK2 toxicity in C. elegans, showing that these pathways are interlinked in vivo and suggesting a link in PD.
引用
收藏
页数:20
相关论文
共 50 条
  • [41] LRRK2 is reduced in Parkinson's disease gut
    de Guilhem de Lataillade, Adrien
    Verchere, Jeremy
    Oullier, Thibauld
    Prigent, Alice
    Durand, Tony
    Pellegrini, Carolina
    Neunlist, Michel
    Baron, Thierry
    Rolli-Derkinderen, Malvyne
    Derkinderen, Pascal
    ACTA NEUROPATHOLOGICA, 2021, 142 (03) : 601 - 603
  • [42] Lrrk2 pathogenic substitutions in Parkinson's disease
    Mata, IF
    Kachergus, JM
    Taylor, JP
    Lincoln, S
    Aasly, J
    Lynch, T
    Hulihan, MM
    Cobb, SA
    Wu, RM
    Lu, CS
    Lahoz, C
    Wszolek, ZK
    Farrer, MJ
    NEUROGENETICS, 2005, 6 (04) : 171 - 177
  • [43] Lrrk2 pathogenic substitutions in Parkinson's disease
    Ignacio F. Mata
    Jennifer M. Kachergus
    Julie P. Taylor
    Sarah Lincoln
    Jan Aasly
    Timothy Lynch
    Mary M. Hulihan
    Stephanie A. Cobb
    Ruey-Meei Wu
    Chin-Song Lu
    Carlos Lahoz
    Zbigniew K. Wszolek
    Matthew J. Farrer
    Neurogenetics, 2005, 6 : 171 - 177
  • [44] LRRK2 as a therapeutic target in Parkinson's disease
    Tan, E. K.
    Schapira, A. H.
    EUROPEAN JOURNAL OF NEUROLOGY, 2011, 18 (04) : 545 - 546
  • [45] LRRK2 and the Endolysosomal System in Parkinson's Disease
    Erb, Madalynn L.
    Moore, Darren J.
    JOURNAL OF PARKINSONS DISEASE, 2020, 10 (04) : 1271 - 1291
  • [46] Targeting LRRK2 mutations in Parkinson's disease
    Lesniak, Robert K.
    Nichols, Robert Jeremy
    Smith, Mark
    Montine, Thomas J.
    FUTURE MEDICINAL CHEMISTRY, 2022, 14 (16) : 1167 - 1170
  • [47] LRRK2 in Parkinson's disease: biochemical functions
    Anand, Vasanti S.
    Braithwaite, Steven P.
    FEBS JOURNAL, 2009, 276 (22) : 6428 - 6435
  • [48] Pathological Functions of LRRK2 in Parkinson's Disease
    Jeong, Ga Ram
    Lee, Byoung Dae
    CELLS, 2020, 9 (12) : 1 - 19
  • [49] LRRK2 activation in idiopathic Parkinson's disease
    Di Maio, Roberto
    Hoffman, Eric K.
    Rocha, Emily M.
    Keeney, Matthew T.
    Sanders, Laurie H.
    De Miranda, Briana R.
    Zharikov, Alevtina
    Van Laar, Amber
    Stepan, Antonia F.
    Lanz, Thomas A.
    Kofler, Julia K.
    Burton, Edward A.
    Alessi, Dario R.
    Hastings, Teresa G.
    Greenamyre, J. Timothy
    SCIENCE TRANSLATIONAL MEDICINE, 2018, 10 (451)
  • [50] Protein synthesis is suppressed in sporadic and familial Parkinson's disease by LRRK2
    Deshpande, Prasannakumar
    Flinkman, Dani
    Hong, Ye
    Goltseva, Elena
    Siino, Valentina
    Sun, Lihua
    Peltonen, Sirkku
    Elo, Laura L.
    Kaasinen, Valtteri
    James, Peter
    Coffey, Eleanor T.
    FASEB JOURNAL, 2020, 34 (11): : 14217 - 14233